| nitial combination of linagliptin and metformin compared with linagliptin monotherapy in patients with newly diagnosed type 2 diabetes and marked hyperglycaemia: a randomized, double-blind, active-controlled, parallel group, multinational clinical trial |
Diabetes, Obesity and Metabolism 17: 136–144, 2015. |
|
|
| A randomised controlled trial of linagliptin monotherapy vs initial combination with metformin in newly diagnosed type 2 diabetes patients |
IDF 2013 Conference, Melbourne, Australia |
|
|
| Oral glucose lowering with linagliptin plus metformin is a viable initial treatment strategy in patients with newly diagnosed type 2 diabetes and marked hyperglycaemia |
European Association for the Study of Diabetes (EASD) |
|
|
| Oral Glucose Lowering With Linagliptin Plus Metformin is a Viable Initial Treatment Strategy in Patients With Newly Diagnosed Type 2 Diabetes and Marked Hyperglycemia |
150?OR, American Diabetes Association 74th Scientific Sessions, June 13–17, 2014, San Francisco, CA, USA |
|
|
